Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults
- PMID: 28336724
- PMCID: PMC5417830
- DOI: 10.1074/mcp.M116.066720
Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults
Abstract
Human blood plasma is a complex biological fluid containing soluble proteins, sugars, hormones, electrolytes, and dissolved gasses. As plasma interacts with a wide array of bodily systems, changes in protein expression, or the presence or absence of specific proteins are regularly used in the clinic as a molecular biomarker tool. A large body of literature exists detailing proteomic changes in pathologic contexts, however little research has been conducted on the quantitation of the plasma proteome in age-specific, healthy subjects, especially in pediatrics. In this study, we utilized SWATH-MS to identify and quantify proteins in the blood plasma of healthy neonates, infants under 1 year of age, children between 1-5 years, and adults. We identified more than 100 proteins that showed significant differential expression levels across these age groups, and we analyzed variation in protein expression across the age spectrum. The plasma proteomic profiles of neonates were strikingly dissimilar to the older children and adults. By extracting the SWATH data against a large human spectral library we increased protein identification more than 6-fold (940 proteins) and confirmed the concentrations of several of these using ELISA. The results of this study map the variation in expression of proteins and pathways often implicated in disease, and so have significant clinical implication.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
References
-
- Lull M. E., Freeman W. M., Myers J. L., Midgley F., Kimatian S. J., Undar A., and Vrana K. E. (2006) Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery. ASAIO J. 52, 562–566 - PubMed
-
- Michiels J. J., Brenneman Z., Gadisseur A., van der Planken M., Schroyens W., van de Velde A., and van Vliet H. (2006) Classification and characterization of herediary types 2A, 2B, 2C, 2D, 2E, 2M, 2N and 2U (unclassifiable) von Wilebrand disease. Clin. App. Thromb. Hemost. 12, 397–420 - PubMed
-
- Kakhniashvili D. G., Griko N. B., Bulla L. A. Jr., and Goodman S. R. (2005) The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp. Biol. Med. 230, 787–792 - PubMed
-
- Yocum A. K., Busch C. M., and Felix C. A. (2006) Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. J. Proteome Res. 5, 2743–2753 - PubMed
-
- Roxo-Rosa M., da Costa G., and Luider T. M. (2006) Proteomic analysis of nasal cells from cystic fibrosis patients and noncystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics 6, 2314–2325 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
